JE
Jabir Ekkaden
About Jabir Ekkaden
Data last updated:
Jabir Ekkaden is a Director at Lifax Pharma Private Limited (since 2025) and Designated Partner at Docone Healthcare Llp (since 2024). The companies operate in Healthcare. The largest current company by reported revenue is Lifax Pharma Private Limited at ₹19.03 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lifax Pharma Private Limited U85100KL2019PTC060715 | Director | 31 Mar 2025 | 2019 | ₹19.03 Cr (FY 2024) | Active |
| Docone Healthcare Llp ACG-3678 | Designated Partner | 01 Apr 2024 | 2024 | Active |
Board colleagues of Jabir Ekkaden
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akzer Thaha | 09491374 | Lifax Pharma Private Limited | Director |
| Mohamed Abdul Rahim Pathiya Parambath Aboobaker | 03352691 | Lifax Pharma Private Limited | Director |
| Shadiya Trikkannoor Kolathode | 10573516 | Docone Healthcare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jabir Ekkaden
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jabir Ekkaden
Jabir Ekkaden currently holds 2 directorships: Lifax Pharma Private Limited (Director, since 31 Mar 2025, revenue ₹19.03 Cr (FY 2024)); Docone Healthcare Llp (Designated Partner, since 01 Apr 2024).
Jabir Ekkaden was first appointed on 01 Apr 2024 as Designated Partner at Docone Healthcare Llp. The most recent appointment on record is 31 Mar 2025 at Lifax Pharma Private Limited.
The current boards of Jabir Ekkaden's companies include Akzer Thaha (Lifax Pharma Private Limited), Mohamed Abdul Rahim Pathiya Parambath Aboobaker (Lifax Pharma Private Limited), Shadiya Trikkannoor Kolathode (Docone Healthcare Llp).